Although most HIV-1 vaccines aim at triggering production of neutralizing antibodies, observations from IgG3 and IgM Fc-mediated effector functions in some STIs provide additional avenues that, when harnessed, may aid in curbing HIV-1 transmissions and disease progression. This evidence concerns the gene IGHG3 and sexually transmitted disease.